Violence Against Women (VAW)FdsVC-WAST-uNCT07827534
Feasibility of Systematic Domestic Violence Screening Using WAST in the Villefranche/Saône Emergency Department.
An observational study of Violence Against Women (VAW), run by L'hôpital Nord-Ouest - Villefranche Villefranche sur Saône at 1 site in France.
Trial summary
This single-center observational study aims to assess the feasibility of systematically screening for intimate partner violence (IPV) against women in the emergency department of Hôpital Nord-Ouest de Villefranche-sur-Saône. Read more about this study
- Who is it for?
- Ages 18 years and older, women only
- Conditions the study is for
- Violence Against Women (VAW)
- What is being tested?
- Self-questionnaire
- How many people
- 100 participants
- Where
- 1 siteFrance
- Study dates
- 7 Apr 2025to 1 Jun 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- No healthy volunteers
- Adult, Older adult
Study population: Adult female patients presenting spontaneously to the Emergency Department of Villefranche-sur-Saône Hospital who meet all inclusion criteria and none of the exclusion criteria. The required sample size is estimated at 101 participants.
Who may be able to join
- Female
- Aged 18 years or older
- Able to read and write French
Who cannot join
- Refusal to participate in the study
- Neurocognitive disorders, confusion, or psychotic disorders that preclude study participation
- Severe uncorrected sensory impairment
- Life-threatening emergency requiring immediate management in the resuscitation area
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Etude de faisabilité d'un dépistage systématique Des Violences Conjugales Envers Les Femmes Par l'Utilisation de l'Auto-questionnaire WAST (Woman Abuse Screening Tool) Dans le Service Des Urgences de l'hôpital Nord-Ouest de Villefranche/Saône.
This single-center observational study aims to assess the feasibility of systematically screening for intimate partner violence (IPV) against women in the emergency department of Hôpital Nord-Ouest de Villefranche-sur-Saône. The study utilizes the Woman Abuse Screening Tool (WAST), a self-administered questionnaire, to identify cases of IPV. The primary objective is to evaluate the feasibility and acceptability of implementing this systematic screening within an emergency setting. The study will measure feasibility through factors such as the implementation rate and adherence by healthcare staff, while acceptability will be assessed based on patient participation and response rates. By analyzing these criteria, the study seeks to determine whether IPV screening can be effectively integrated into routine emergency care. The findings are expected to provide insights into potential barriers and facilitators for screening implementation, contributing to improved detection and support strategies for women experiencing domestic violence.
- Conditions
- Violence Against Women (VAW)
- Being tested
- Self-questionnaire
- Keywords
- Patient Acceptability, Woman Abuse Screening Tool (WAST), Screening Feasibility, Intimate Partner Violence (IPV), Violence Against Women (VAW)
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Self-questionnaireOther
Self-questionnaire completed in the waiting room of the emergency department, either on paper or online by scanning a QR-code
What is being measured
The primary outcome is the main question the study is designed to answer.
Feasibility of systematic screening using WAST
Assessed by the proportion of eligible women screened with WAST.
Measured: At the time of outpatient consultation (Day 0)
Acceptability of WAST
Assessed using an acceptability questionnaire completed by healthcare patient
Measured: At the time of outpatient consultation (Day 0)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Sep 2026
- Study start7 Apr 2025
- Primary completion1 Jun 2025
- Study completion1 Jun 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Violence Against Women (VAW)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 100 participants (actual)
Sponsor and investigators
- Lead sponsor
- L'hôpital Nord-Ouest - Villefranche Villefranche sur Saône
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- LUCIE TEYSSIER, GENERAL MEDECINE, Study chair
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07827534
- Sponsor's protocol ID
- HNO25_001
- Other IDs
- 2025-A00252-47
- Acronym
- FdsVC-WAST-u
- Status last verified
- Sep 2026
- First submitted
- 5 May 2025
- Last updated
- 18 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 18 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Etude de faisabilité d'un dépistage systématique Des Violences Conjugales Envers Les Femmes Par l'Utilisation de l'Auto-questionnaire WAST (Woman Abuse Screening Tool) Dans le Service Des Urgences de l'hôpital Nord-Ouest de Villefranche/Saône.
- ClinicalTrials.gov ID
- NCT07827534
- Acronym / sponsor ID
- FdsVC-WAST-u / HNO25_001
- Conditions
- Violence Against Women (VAW)
- Keywords
- Patient Acceptability, Woman Abuse Screening Tool (WAST), Screening Feasibility, Intimate Partner Violence (IPV), Violence Against Women (VAW)
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 100 participants (actual)
- Lead sponsor
- L'hôpital Nord-Ouest - Villefranche Villefranche sur SaôneUniversity, hospital or other
- Study start
- 7 Apr 2025 (actual)
- Primary completion
- 1 Jun 2025 (actual)
- Study completion
- 1 Jun 2025 (actual)
- First posted
- 18 Sep 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This single-center observational study aims to assess the feasibility of systematically screening for intimate partner violence (IPV) against women in the emergency department of Hôpital Nord-Ouest de Villefranche-sur-Saône. The study utilizes the Woman Abuse Screening Tool (WAST), a self-administered questionnaire, to identify cases of IPV. The primary objective is to evaluate the feasibility and acceptability of implementing this systematic screening within an emergency setting. The study will measure feasibility through factors such as the implementation rate and adherence by healthcare staff, while acceptability will be assessed based on patient participation and response rates. By analyzing these criteria, the study seeks to determine whether IPV screening can be effectively integrated into routine emergency care. The findings are expected to provide insights into potential barriers and facilitators for screening implementation, contributing to improved detection and support strategies for women experiencing domestic violence.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Adult female patients presenting spontaneously to the Emergency Department of Villefranche-sur-Saône Hospital who meet all inclusion criteria and none of the exclusion criteria. The required sample size is estimated at 101 participants.
Key inclusion criteria (3 listed)
- Female
- Aged 18 years or older
- Able to read and write French
Key exclusion criteria (4 listed)
- Refusal to participate in the study
- Neurocognitive disorders, confusion, or psychotic disorders that preclude study participation
- Severe uncorrected sensory impairment
- Life-threatening emergency requiring immediate management in the resuscitation area
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Self-questionnaireSelf-questionnaire completed in the waiting room of the emergency department, either on paper or online by scanning a QR-code | Other | – |
Primary outcome
Feasibility of systematic screening using WAST
Time frame: At the time of outpatient consultation (Day 0)
Assessed by the proportion of eligible women screened with WAST.
Acceptability of WAST
Time frame: At the time of outpatient consultation (Day 0)
Assessed using an acceptability questionnaire completed by healthcare patient
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Sep 2026.
Related trials for Violence Against Women (VAW)
Enrolling by invitation
Effect of Moulage-Based Performance on Violence Against Women Awareness
Violence Against Women (VAW), Domestic Violence
Not yet recruitingObservational study
Female Trauma Cases
Violence Against Women (VAW)
Not yet recruiting
The Effect of Laughter Yoga-Supported Strong Woman, Safe Life Training Program on Attitudes Towards Violence, Styles of Coping with Stress and Psychological Flexibility
Violence Against Women (VAW), Laughter Yoga
Active, not recruitingObservational study
Requests for Voluntary Termination and Medical Termination of Pregnancy for Maternal, Psychological or Social Reasons At the Women's Center ( La Maison Des Femmes) in Saint-Denis :
Pregnancy, Violence Against Women (VAW)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
LUCIE TEYSSIER, GENERAL MEDECINE study chair
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Violence Against Women (VAW), run by L'hôpital Nord-Ouest - Villefranche Villefranche sur Saône at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Feasibility of systematic screening using WAST (time frame: At the time of outpatient consultation (Day 0)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Sep 2026.